These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. Blonde L; Dempster J; Gallivan JM; Warren-Boulton E J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330 [TBL] [Abstract][Full Text] [Related]
7. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U; Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089 [TBL] [Abstract][Full Text] [Related]
8. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population. Cheung BM; Cheng CH; Lau CP; Wong CK; Ma RC; Chu DW; Ho DH; Lee KL; Tse HF; Wong AS; Yan BP; Yan VW Hong Kong Med J; 2017 Apr; 23(2):191-201. PubMed ID: 28387202 [TBL] [Abstract][Full Text] [Related]
9. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions. Lonn E; Grewal J Curr Vasc Pharmacol; 2006 Jul; 4(3):253-68. PubMed ID: 16842143 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents]. Auer J; Berent R; Weber T; Porodko M; Mayr H; Maurer E; Eber B Wien Med Wochenschr; 2001; 151(1-2):13-7. PubMed ID: 11234591 [TBL] [Abstract][Full Text] [Related]
14. Modifiable risk factors for the primary prevention of heart disease in women. Hong S; Friedman J; Alt S J Am Med Womens Assoc (1972); 2003; 58(4):278-84. PubMed ID: 14640260 [TBL] [Abstract][Full Text] [Related]
15. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study. Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572 [TBL] [Abstract][Full Text] [Related]
16. Heartwatch: a secondary prevention programme in primary care in Ireland. Bennett K; Jennings S; Collins C; Boland M; Leahy J; Bedford D; Shelley E Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):651-6. PubMed ID: 19177599 [TBL] [Abstract][Full Text] [Related]
17. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen mL; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ; ; Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():S1-113. PubMed ID: 17726407 [No Abstract] [Full Text] [Related]
18. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)]. Zidek W MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807 [No Abstract] [Full Text] [Related]
19. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]